Skip to main content
Clinical Trials/CTRI/2022/08/045106
CTRI/2022/08/045106
Recruiting
未知

Echocardiographic Assessment of Different Mechanisms of Ischemic Mitral Regurgitation in Patients with Inferior and Anterior Myocardial Infarction

Fortis Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Fortis Hospital
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \>\= 18 years.
  • Prior inferior or anteroseptal MI diagnosed on the basis of a history of acute MI more than one month before with rise and/or fall of cardiac biomarkers above the 99th percentile of the upper reference limit with ST elevation in anterior or inferior leads on ECG and segmental left ventricular wall motion abnormality of the inferior or anteroseptal wall.
  • Moderate or severe mitral regurgitation diagnosed on the basis of vena contracta width \>\= 0\.3 cm and/or Jet/LA area \>\= 20% and/or MR regurgitant volume \>\= 30 ml as per 2017 American Society of Echocardiography (ASE) guidelines.

Exclusion Criteria

  • Recent MI ( \< 1 month)
  • Multiple MIs
  • Previous heart surgery
  • MR caused by organic mitral valvular lesions (including rheumatic changes, chordal or papillary muscle rupture, and infective endocarditis)
  • Other associated cardiac diseases, such as aortic valve or congenital heart disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials